Skip to main content
. 2017 Jul 19;24:47. doi: 10.1186/s12929-017-0355-7

Fig. 1.

Fig. 1

Classification of therapeutic drugs or targets in the treatment of Alzheimer’s disease according to neuropathological hallmarks